Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea

被引:31
作者
Surawicz, Christina M. [1 ]
机构
[1] Univ Washington SOM, Seattle, WA 98104 USA
关键词
antibiotic-associated diarrhea; Clostridium difficile; recurrent Clostridium difficile; Lactobacillus GG; Saccharomyces boulardii;
D O I
10.1097/MCG.0b013e3181646d09
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea, Clostridium difficile diarrhea, and recurrent C. difficile diarrhea is reviewed. Various probiotics have variable efficacy. More studies are needed to define further their efficacies, roles, and indications.
引用
收藏
页码:S64 / S70
页数:7
相关论文
共 74 条
[41]  
MCFARLAND LV, 1995, AM J GASTROENTEROL, V90, P439
[42]   EPIDEMIOLOGY OF INFECTIOUS AND IATROGENIC NOSOCOMIAL DIARRHEA IN A COHORT OF GENERAL MEDICINE PATIENTS [J].
MCFARLAND, LV .
AMERICAN JOURNAL OF INFECTION CONTROL, 1995, 23 (05) :295-305
[43]   RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SACCHAROMYCES-BOULARDII IN COMBINATION WITH STANDARD ANTIBIOTICS FOR CLOSTRIDIUM-DIFFICILE DISEASE [J].
MCFARLAND, LV ;
SURAWICZ, CM ;
GREENBERG, RN ;
FEKETY, R ;
ELMER, GW ;
MOYER, KA ;
MELCHER, SA ;
BOWEN, KE ;
COX, JL ;
NOORANI, Z ;
HARRINGTON, G ;
RUBIN, M ;
GREENWALD, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (24) :1913-1918
[44]   Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells [J].
Miettinen, M ;
Matikainen, S ;
Vuopio-Varkila, J ;
Pirhonen, J ;
Varkila, K ;
Kurimoto, M ;
Julkunen, I .
INFECTION AND IMMUNITY, 1998, 66 (12) :6058-6062
[45]   Saccharomyces cerevisiae fungemia:: An emerging infectious disease [J].
Muñoz, P ;
Bouza, E ;
Cuenca-Estrella, M ;
Eiros, JM ;
Pérez, MJ ;
Sánchez-Somolinos, M ;
Rincón, C ;
Hortal, J ;
Peláez, T .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1625-1634
[46]   Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole [J].
Musher, DM ;
Aslam, S ;
Logan, N ;
Nallacheru, S ;
Bhaila, I ;
Borchert, F ;
Hamill, RJ .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1586-1590
[47]   Fungemia due to Saccharomyces species in a patient treated with enteral Saccharomyces boulardii [J].
Niault, M ;
Thomas, F ;
Prost, J ;
Ansari, FH ;
Kalfon, P .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) :930-930
[48]   EFFECT OF SUPPLEMENTS WITH BIFIDOBACTERIUM-LONGUM AND LACTOBACILLUS-ACIDOPHILUS ON THE INTESTINAL MICROBIOTA DURING ADMINISTRATION OF CLINDAMYCIN [J].
ORRHAGE, K ;
BRISMAR, B ;
NORD, CE .
MICROBIAL ECOLOGY IN HEALTH AND DISEASE, 1994, 7 (01) :17-25
[49]   Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada [J].
Pépin, J ;
Alary, ME ;
Valiquette, L ;
Raiche, E ;
Ruel, J ;
Fulop, K ;
Godin, D ;
Bourassa, C .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (11) :1591-1597
[50]   SYMPOSIUM - PROBIOTIC BACTERIA FOR HUMANS - CLINICAL-SYSTEMS FOR EVALUATION OF EFFECTIVENESS - IMMUNE-SYSTEM STIMULATION BY PROBIOTICS [J].
PERDIGON, G ;
ALVAREZ, S ;
RACHID, M ;
AGUERO, G ;
GOBBATO, N .
JOURNAL OF DAIRY SCIENCE, 1995, 78 (07) :1597-1606